Faculty: Biography

Ralph A. Tripp, Ph.D.
Professor and GRA Chair
Infectious Diseases
Address: Animal Health Research Center
University of Georgia
Athens, GA 30601
Office: 201
Phone: (706) 542-1557
Email: ratripp@uga.edu
Biosketch
Ph.D.Oregon State UniversityCorvallis, OR1989
Post-doctoral Experience
- 2 year National Research Fellowship; Adenovirus Immune Evasion Mechanisms;
Linda Gooding; Emory University, Atlanta, GA
-2 year fellowship; T cell Memory Response to Influenza Virus; Peter C.
Doherty; St. Jude Children's Research Hospital, Memphis, TN
Honors and Awards
Georgia Research Alliance Eminent Scholar and Endowed Chair in Vaccine and Therapeutic Studies; Outstanding Service Award to University of Georgia and the State of Georgia; Service Award presented by the Georgia Veterinary Scholars; NIAID Special Recognition Award for Extraordinary Work in H1N1 Influenza Research; Honors Award - Center for Undergraduate Research Opportunities at UGA; Georgia BioBusiness Academic Entrepreneur of the Year; McMaster’s Fellow
Research Interests
The Tripp lab develops translational disease intervention strategies and countermeasures for important human pathogens and emerging infectious diseases of zoonotic origin. His labs investigate the mechanisms of immunity, the virus-host interface, and disease pathogenesis to understand the dynamics of host response to infection and to provide new strategies for resolving disease.
Representative Publications
Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis. Immune Netw. 2013 PMID: 24198740

Targeting cell division cycle 25 homolog B to regulate influenza virus replication. J Virol. 2013 Epub 2013

Modeling Respiratory Syncytial Virus Cytopathogenesis in the Human Airway.Am J Respir Crit Care Med. 2013 PMID: 24083857

Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease. PLoS One. 2013 PMID: 24040360

Advances in and the potential of vaccines for respiratory syncytial virus. Expert Rev Respir Med. 2013 PMID: 23964629
[back to top]